Search results
Results From The WOW.Com Content Network
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB.. The medical standard for active TB is a short course treatment involving a combination of isoniazid, rifampicin (also known as Rifampin), pyrazinamide, and ethambutol for the first two months.
Multidrug-resistant tuberculosis (MDR-TB) is a form of tuberculosis (TB) infection caused by bacteria that are resistant to treatment with at least two of the most powerful first-line anti-TB medications (drugs): isoniazid and rifampicin.
Tuberculosis; Other names: Phthisis, phthisis pulmonalis, consumption, great white plague: Chest X-ray of a person with advanced tuberculosis: Infection in both lungs is marked by white arrow-heads, and the formation of a cavity is marked by black arrows.
Development of disadvantaged regions programs was started under the Abdurrahman Wahid presidency. At that time, the post of Undersecretariat of Acceleration of Development in Eastern Indonesia Affairs of the Republic of Indonesia (Indonesia: Menteri Muda Urusan Percepatan Pembangunan Kawasan Timur Indonesia Republik Indonesia) created by him through Presidential Decision No. 234/M/2000 on ...
Side effects are those of the underlying medications. [1] Common side effects include poor coordination, poor appetite, nausea, numbness, and feeling tired. [3] More severe side effects include liver problems. [3]
Scanning electron micrograph of Mycobacterium tuberculosis. Tuberculosis is a serious public health problem in China. [1] China has the world's third largest cases of tuberculosis (after India and Indonesia), but progress in tuberculosis control was slow during the 1990s.
A combination drug or a fixed-dose combination (FDC) is a medicine that includes two or more active ingredients combined in a single dosage form. [1] Terms like "combination drug" or "combination drug product" can be common shorthand for an FDC product (since most combination drug products are currently FDCs), although the latter is more precise if in fact referring to a mass-produced product ...
Köhler's Medicinal Plants (or, Köhler's Medizinal-Pflanzen) is a German herbal written principally by Hermann Adolph Köhler (1834–1879, physician and chemist), and edited after his death by Gustav Pabst.